Lithium salts

Lithium salts appear as a recurring part of Emma’s psychiatric medication, not as a cure that removes the difficulties around her illness. They are taken alongside other drugs, considered in discussions of treatment and possible pregnancy, and implicated in both an accidental extra dose and a dispute over keeping medication at home. Across these episodes, the pills are at once clinical tools and objects around which questions of risk, trust, and control gather.

Medication and treatment

When Emma explains that unsettling changes began after she started new medication, she names lithium, temazepam, and Tegretol, which she had begun only a few days earlier. She suspects the new treatment may account for what is happening, while another speaker identifies Tegretol as a drug used for epilepsy. Emma understands its relevance to her treatment through its intended mood-stabilizing effect. Lithium is thus introduced in a practical list of medicines, as part of a changing regimen rather than an isolated remedy.

Later, Rajid Panjani discusses rapid cycling and a possible adjustment to treatment. He presents the frequency and duration of Emma’s mood shifts as something medication may help reduce, and proposes beginning Depakine alongside lithium. Because the response to a new drug cannot yet be known, he wants Emma to remain in the PAAZ for at least two weeks while the dose is increased, possibly longer if needed. Lithium is the continuing medication against which this addition is considered; the plan also makes clear that treatment involves observation and time, not simply sending a patient home with a prescription.

The prospect of that supervised medication period shapes Emma’s immediate plans. She is permitted a brief visit to her parents before beginning the new pills on Sunday evening, while Sergei is abroad. Her return home is therefore temporary and bounded by the treatment schedule. In the narrative, medication links the routines of the ward to the uncertain possibility of life outside it: home is anticipated, but the next stage of care remains active and unresolved.

Pregnancy and bodily risk

Lithium becomes especially charged when Emma challenges a doctor’s cheerful response to the possibility that she might be pregnant. She points out that she has been taking lithium and sleeping medication and has just tried Tegretol; the thought of a pregnancy under those circumstances makes congratulations feel grotesquely misplaced to her. Her anger is directed not only at the medications but at a response that seems to treat pregnancy as welcome news before addressing what she understands to be the real danger.

The doctor replies that medication does not necessarily rule out pregnancy and offers referral to a specialist clinic that advises women who want children while taking medication, coordinating treatment with safety for mother and child in mind. The exchange does not settle Emma’s concern. Instead, it exposes a divide between medical reassurance about available guidance and her immediate sense that her body and circumstances have not been adequately considered. Lithium matters here as a concrete element of treatment with possible consequences beyond mood management; the scene gives Emma’s objection its force without resolving the medical question.

Extra medication and control at home

Emma recalls taking one extra lithium tablet by accident and describes the experience as a reason not to repeat it. The account establishes a specific medication error, but does not detail its symptoms or give a dosage. Its significance lies in how it sharpens her refusal to treat pills casually: even an unintentional extra tablet is remembered as an unpleasant experience, not as evidence of recreational use.

That distinction surfaces in a conversation about drugs and the idea of taking more pills. Emma’s response is dry rather than adventurous; her past mistake serves as a boundary. Elsewhere, the larger issue of medication control enters her relationship with Sergei. At her psychiatrist’s request, he is supposed to remove Emma’s stored pills, but he resists for more than three weeks. It takes two conversations with the psychiatrist before he finally does so, and even then Emma feels he is not fully willing. The passage does not identify every stored pill as lithium, so the dispute is best understood as a conflict over her medication supply more broadly, rather than as a claim about lithium alone.

A fellow patient offers a possible interpretation of Sergei’s reluctance: perhaps treating Emma’s problems as less serious protects him from facing how life-threatening they might be. Emma responds with wounded irony, asking whether that makes her the danger. The exchange shows that removing pills is not merely a practical intervention. It also carries the emotional burden of admitting that Emma’s crisis could have consequences Sergei fears. The psychiatrist’s request, Sergei’s delay, and Emma’s experience of not being taken seriously give medication control a relational dimension.

Narrative significance

Lithium’s meaning changes with the circumstances in which it appears. In the treatment discussion, it is the established medication alongside which Rajid proposes Depakine; in Emma’s accidental extra dose, it is a pill whose effects she does not want to repeat; in the pregnancy argument, it becomes part of a bodily risk she feels the doctor has glossed over. These meanings do not make the drug itself a villain or a solution. They show how one medicine can occupy several contested roles in a patient’s life.

The book also places medication within a broader uncertainty about mental illness and care. Emma’s suicidal thinking had become, to her, an apparently clear imperative rather than a plan she recognized as alarming; afterward, treatment involves naming mood patterns, weighing a new drug, and extending observation. Lithium belongs to that process, but it cannot by itself explain Emma’s experience or guarantee an uncomplicated recovery. Its recurring presence makes visible the practical and intimate stakes of psychiatric treatment: what a medicine may do, who decides how it is used, and how seriously the people closest to the patient acknowledge the danger.